🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Severe or Greater Tricuspid Regurgitation

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) NCT06212193NA12 sites📍 Thousand Oaks📍 Detroit📍 Rochester Innoventric LTD · Tests: Trillium™ Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial) NCT07454980NA7 sites📍 Naples📍 The Bronx📍 Vancouver Jenscare Innovation Inc. · Tests: TTVI with LuX-Valve Plus System, TTVI with EVOQUE A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems. NCT07433504NA1 site📍 Shanghai Shanghai Huihe Medical Technology Co., Ltd · Tests: Experimental: Transcatheter tricuspid valve repair using the transcatheter tricuspid valve clipping system +GDMT, Guide… First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation NCT07536724NA2 sites📍 Tashkent📍 Tashkent Medira GmbH · Tests: TRICENTOG2 Transcatheter Valve System for Tricuspid Regurgitation (TRICENTOG2 TVSTR)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy